NL-103, a novel dual-targeted inhibitor of histone deacetylases and hedgehog pathway, effectively overcomes vismodegib resistance conferred by Smo mutations.
about
Hedgehog signaling: modulation of cancer properies and tumor mircroenvironmentEpigenetic polypharmacology: from combination therapy to multitargeted drugsSynthetic Small Molecule Inhibitors of Hh Signaling As Anti-Cancer Chemotherapeutics.Acute myeloid leukemia - strategies and challenges for targeting oncogenic Hedgehog/GLI signalingMultitarget Drugs: an Epigenetic Epiphany.Basal cell carcinoma pathogenesis and therapy involving hedgehog signaling and beyond.Role of Vismodegib in the Management of Advanced Periocular Basal Cell Carcinoma.Combined inhibition of atypical PKC and histone deacetylase 1 is cooperative in basal cell carcinoma treatment.A synthetic combinatorial approach to disabling deviant Hedgehog signaling.Role of GLI Transcription Factors in Pathogenesis and Their Potential as New Therapeutic Targets
P2860
Q26764740-372814C9-047D-45BF-9DB4-BC9042156722Q28067666-ABF4E557-C25B-40E5-B683-16259A47349FQ35756696-7AC33B97-59E6-44A5-9F26-5962FBD9FCDDQ37607838-2CFAA8F5-CEBA-4208-ABC4-05A06FF39C90Q38739347-20D266FC-EA7A-4BCC-B7AE-49093A203643Q38748824-E3DA879F-16E3-4333-BFBF-BF146C4559BBQ38842917-9BE9A888-1A99-4BB9-BE22-EC77CA758529Q46767544-A9C8D02A-45A1-413B-B774-D595CF24D4A2Q48215997-0B039093-F300-401F-BE2D-8843B4B6AB67Q58692807-8ACBA64A-EBAF-4F59-8973-4D6EEFB84B76
P2860
NL-103, a novel dual-targeted inhibitor of histone deacetylases and hedgehog pathway, effectively overcomes vismodegib resistance conferred by Smo mutations.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
NL-103, a novel dual-targeted ...... ce conferred by Smo mutations.
@ast
NL-103, a novel dual-targeted ...... ce conferred by Smo mutations.
@en
NL-103, a novel dual-targeted ...... ce conferred by Smo mutations.
@nl
type
label
NL-103, a novel dual-targeted ...... ce conferred by Smo mutations.
@ast
NL-103, a novel dual-targeted ...... ce conferred by Smo mutations.
@en
NL-103, a novel dual-targeted ...... ce conferred by Smo mutations.
@nl
prefLabel
NL-103, a novel dual-targeted ...... ce conferred by Smo mutations.
@ast
NL-103, a novel dual-targeted ...... ce conferred by Smo mutations.
@en
NL-103, a novel dual-targeted ...... ce conferred by Smo mutations.
@nl
P2093
P2860
P356
P1476
NL-103, a novel dual-targeted ...... ce conferred by Smo mutations.
@en
P2093
Chengying Xie
Haitian Quan
Liguang Lou
P2860
P304
P356
10.1002/PRP2.43
P577
2014-04-07T00:00:00Z